Timolol Maleate
Brand name: Timolol Maleate
Rank #375 of 500 drugs by total cost
$25.8M
Total Cost
1,129,537
Total Claims
$25.8M
Total Cost
15,071
Prescribers
$23
Cost per Claim
320,372
Beneficiaries
2,303,750
30-Day Fills
$1,714
Avg Cost/Provider
75
Avg Claims/Provider
About Timolol Maleate
Timolol Maleate (sold as Timolol Maleate) was prescribed 1,129,537 times by 15,071 Medicare Part D providers in 2023, costing the program $25.8M. At $23 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
| 375 | Timolol Maleate (Timolol Maleate) | $25.8M | 1,129,537 |
| 376 | Amitriptyline Hcl (Amitriptyline Hcl) | $25.8M | 1,295,043 |
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology